Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

376.21 +5.99 (+1.62%)

Streaming Delayed Price Updated: 9:46 AM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

21 22 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 08, 2023

Via Benzinga

Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review ↗

May 05, 2023

The major indexes retreated for most of the week on banking fears,

Via Investor's Business Daily

RBC Capital Maintains Outperform Rating for Stryker: Here's What You Need To Know ↗

May 02, 2023

Via Benzinga

What's Going On With Stryker Stock Today ↗

May 02, 2023

The orthopedic and surgical device giant Stryker Corporation (NYSE: SYK) stock is trading lower despite reporting Q1 earnings beat and an upbeat outlook.

Via Benzinga

If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today ↗

May 01, 2023

Via Benzinga

Earnings Preview For Stryker ↗

April 28, 2023

Via Benzinga

Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever ↗

May 03, 2023

These two companies are leaders in their industries, and they're relatively safe, too.

Via The Motley Fool

Strong Sales and Momentum Propel Stryker to Stellar Q1 Results: Analysts Keep a Watchful Eye on Future Profitability ↗

May 02, 2023

Stryker Corporation (NYSE: SYK) reported Q1 sales of $4.80 billion, up 11.8% Y/Y (+14% in constant currency), beating the

Via Benzinga

Stryker Gets Price Target Hikes By Analysts Following Upbeat Q1 Results ↗

May 02, 2023

Stryker Corporation (NYSE: SYK) reported better-than-expected earnings for its first quarter and increased its full-year profit outlook.

Via Benzinga

MGM Resorts To Rally Around 33%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

May 02, 2023

Credit Suisse boosted the price target for KBR, Inc. (NYSE: KBR) from $68 to $71. Credit Suisse analyst Jamie Cook maintained an Outperform rating. KBR shares rose 4.4% to close at $59.16 on Monday.

Via Benzinga

Pfizer, Ford And 3 Stocks To Watch Heading Into Tuesday ↗

May 02, 2023

With US stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

2 Top Stocks to Buy in April and Hold Forever ↗

April 08, 2023

The need for healthcare goods and/or services is here to stay.

Via The Motley Fool

The Latest Analyst Ratings for Stryker ↗

March 28, 2023

Via Benzinga

Stryker reports first quarter 2023 operating results

May 01, 2023

From Stryker Corporation

Via GlobeNewswire

3 Medical Device Stocks Outpacing the Healthcare Industry This Year ↗

May 01, 2023

All three of these companies have seen double-digit increases in their share prices this year.

Via The Motley Fool

Global Payments, MGM Resorts And 3 Stocks To Watch Heading Into Monday ↗

May 01, 2023

With US stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

These 3 Stocks Might Be Getting a Little Too Expensive ↗

April 30, 2023

These are promising businesses, but you might want to hold off on buying shares -- for now.

Via The Motley Fool

Healthcare Innovation Drives Medical Device Makers To New Highs

April 17, 2023

Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base.

Via MarketBeat

Earnings Scheduled For May 1, 2023 ↗

May 01, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

Via Benzinga

Microsoft To Rally Around 9%? Here Are 10 Other Analyst Forecasts For Monday ↗

April 03, 2023

RBC Capital raised the price target for Pinterest, Inc. (NYSE: PINS) from $26 to $30. RBC Capital analyst Brad Erickson maintained a Sector Perform rating. Pinterest shares gained 1.5% to $27.68 in...

Via Benzinga

Stryker to announce financial results for its first quarter of fiscal year 2023

March 30, 2023

From Stryker Corporation

Via GlobeNewswire

Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty

March 30, 2023

From Stryker

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 ↗

March 29, 2023

Via Benzinga

Stryker announces Annual Meeting of Shareholders

March 28, 2023

From Stryker Corporation

Via GlobeNewswire

3 Dividend Champions for Long-Term Income ↗

March 16, 2023

Dividend Champions have grown their dividend payout for at least 25 years in a row. Here are three to keep in mind for long-term income.

Via InvestorPlace

Portfolio Highlights: Quarterly Movers & Shakers, March 2023 ↗

March 14, 2023

High quality stocks that generated strong double-digit gains during the past three months.

Via Talk Markets

Are These Medical Device Makers Getting Ready To Rally?

March 10, 2023

Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors.

Via MarketBeat

BAX: A “Hospital Stock” To Avoid ↗

February 20, 2023

Baxter International's shares are down nearly 50% over the past three years and have underperformed the broader healthcare industry.

Via Talk Markets

Interview With David Rolfe of Wedgewood Partners ↗

February 17, 2023

Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe.

Via The Motley Fool

Stryker's Q Guidance System Scores FDA Clearance For Cranial Applications ↗

February 17, 2023

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.